Pegcetacoplan in idiopathic and familial pediatric C3 glomerulopathy. [PDF]
Pediatr NephrolRomán Ortiz E +7 more
europepmc +1 more source
Deep learning in geographic atrophy: rethinking age-related macular degeneration progression and treatment. [PDF]
Ann Transl MedShiromani S, Chhablani J.
europepmc +1 more source
Off-label intravitreal eculizumab for geographic atrophy: report of the first two cases. [PDF]
Int J Retina VitreousJorge R +3 more
europepmc +1 more source
Effect of Pegcetacoplan on Aqueous Humor Proteome in Geographic Atrophy: A Prospective Exploration. [PDF]
Invest Ophthalmol Vis SciTrivizki O +11 more
europepmc +1 more source
Case Report: Refractory cold agglutinin disease with hypersplenism: efficacy of splenectomy in a patient treated with sutimlimab. [PDF]
Front ImmunolSau A +6 more
europepmc +1 more source
Plain language summary of disease activity and therapeutic response to pegcetacoplan for geographic atrophy identified by deep learning-based analysis of OCT. [PDF]
ImmunotherapySchmidt-Erfurth U +9 more
europepmc +1 more source
Current and Emerging Therapies for C3 Glomerulopathy and Primary (Idiopathic) Immune Complex Membranoproliferative Glomerulonephritis. [PDF]
Kidney Int RepKavanagh D +8 more
europepmc +1 more source
C3 Glomerulopathy Diagnosis, Current Treatments, and Emerging Therapies. [PDF]
Kidney MedMashayekhi M +10 more
europepmc +1 more source
New Anticomplement Drugs in Nephrology: Mechanism and Indication.
Kidney Blood Press ResMacciò L +5 more
europepmc +1 more source